Westlake N-of-1 Trials for Macronutrient Intake 2 ( WE-MACNUTR 2)
Westlake Personalized Nutrition Intervention Study: N-of-1 Trials for Dietary Macronutrient Intake 2
1 other identifier
interventional
11
1 country
1
Brief Summary
Diet and nutrition are key to maintain human health. Westlake N-of-1 Trials for Macronutrient Intake (WE-MACNUTR) trial investigates individualized postprandial glycemic responses to different proportions of dietary fat and carbohydrates intake using an n-of-1 experimental study design. The experimental diets are isocaloric high fat, low carbohydrate (HF-LC) or low fat, high carbohydrate (LF-HC). With standardized intervention and strictly controlled eating behaviors, the WE-MACNUTR study identifies specific HC-responders and HF-responders in terms of postprandial glucose response. This is a follow-up study offered to participants who have completed the WE-MACNUTR study in 2019. Volunteers will be asked to participate in four 5-d periods while wearing glucose monitors (Abbott Freestyle Libre) with the following experimental sequence: 1) a washout diet, 2) HF-LC or LC-HF diet, 3) a washout diet, 4) HF-LC or LC-HF diet. The experimental diet will be randomly assigned. Participants will be asked to provide a fasted blood sample and to collect fecal, urine and saliva samples at each visits.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 30, 2021
CompletedFirst Submitted
Initial submission to the registry
November 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 18, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 19, 2021
CompletedFirst Posted
Study publicly available on registry
December 17, 2021
CompletedJune 1, 2022
October 1, 2021
19 days
November 18, 2021
May 27, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood glucose profiling
Real-time blood glucose fluctuations will be recorded by CGM.
20 days
Other Outcomes (6)
Urines untargeted metabolomics profiling
Day 6, day 11 day 16 and day 21 of the study
Fecal targeted metabolomics profiling
Day 6, day 11 day 16 and day 21 of the study
Microbiome taxonomic profiling
Day 6, day 11 day 16 and day 21 of the study
- +3 more other outcomes
Study Arms (2)
High fat, low carbohydrate diet
EXPERIMENTALLow fat, high carbohydrate diet
EXPERIMENTALInterventions
Throughout the 5-day intervention, participants are provided with a high fat, low carbohydrate (HF-LC) diet in which the percentage of fat, protein and carbohydrate is 60%, 15% and 25%, respectively.
Throughout the 5-day intervention, participants are provided with a low fat, high carbohydrate (LF-HC) diet in which the percentage of fat, protein and carbohydrate is 10%, 15% and 75%, respectively.
Eligibility Criteria
You may qualify if:
- Participants have completed WE-MACNUTR trial in 2019
- Participants have no traveling plans within 1 months
- Participants are able and willing to comply with the study protocol and provide informed consent
You may not qualify if:
- Refuse or are unable to provide informed consent to participate in the study
- Have long-term gastrointestinal diseases and take daily relevant medications
- Have taken antibiotics in the last 2 weeks
- Have type 2 diabetes and are taking medications or other treatments
- Have chronic or acute liver disease and are taking medications or other treatments
- Have cardiovascular diseases and are taking medications or other treatments
- Have kidney disease and are taking medications
- Suffer from chronic anxiety or depression, or other critical neuronal disorder and/or history of relevant medication
- Are pregnant or lactating, or are planning to be pregnant in the next 3 months
- Diagnosed with an eating disorder (e.g. anorexia nervosa or bulimia nervosa)
- Are vegan, or unwilling to consume foods provided in the study
- Have history of alcohol or drug addiction, or smoke above 15 cigarettes per day
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Westlake University
Hangzhou, Zhejiang, 310024, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ju-Sheng Zheng, PhD
Westlake University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 18, 2021
First Posted
December 17, 2021
Study Start
October 30, 2021
Primary Completion
November 18, 2021
Study Completion
November 19, 2021
Last Updated
June 1, 2022
Record last verified: 2021-10